Paradoxically, clinical observations have revealed elevated hepatic PPARγ expression in MASH cases [61,62], and PPARγ-deficient murine models exhibit resistance to diet-induced MASH [22]. Here, PPARG is linked to metabolic dysfunction-associated steatohepatitis.